Advertisement

Topics

Drug makers deserve to be publicly shamed for thwarting competition from generics

12:53 EDT 7 Aug 2017 | STAT

Pharma often thwarts competition by refusing to turn over the samples a generics company needs to get a cheaper product approved. The FDA is cracking down.

Original Article: Drug makers deserve to be publicly shamed for thwarting competition from generics

NEXT ARTICLE

More From BioPortfolio on "Drug makers deserve to be publicly shamed for thwarting competition from generics"

Quick Search
Advertisement
 

Relevant Topic

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...